The FINANCIAL — Eli Lilly and Company and Boehringer Ingelheim Pharmaceuticals, Inc. announced on December 15 that BASAGLAR (insulin glargine injection 100 units/mL) is available by prescription in ...
Some people with diabetes require insulin. They can manually administer this through several methods, such as syringes, which are available in different sizes with various-sized needles. There are ...
For people with diabetes who inject insulin, the syringe and needle size can make a big difference in comfort and staying on track with steady blood sugar levels. According to a 2024 statistics report ...
PARIS, June 14, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that, in a pooled analysis, investigational therapy Toujeo ® (insulin glargine [rDNA origin] injection, 300 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback